Fig. 3From: Assessment of disease activity using a whole-body MRI derived radiological activity index in chronic nonbacterial osteomyelitisRAI-CROMRIS at baseline and at 6 months in patients treated with bisphosphonates. The distribution of RAI-CROMRIS values (A) and of the extension of bone hyperintensity (B) at baseline and at 6 months in 27 patients who received bisphosphonates with MRI at baseline (T0) and at 6 months (T6) were analysedBack to article page